Aeovian Pharmaceuticals is a San Francisco-based biopharmaceutical company focused on developing innovative and selective therapeutics that target the mTORC1 pathway. Their work aims to address significant challenges in the biotechnology and life sciences fields, contributing to advancements in treatment options and patient care.
What industry does Aeovian Pharmaceuticals belong to?
Aeovian Pharmaceuticals belongs to the Biotechnology, Pharmaceuticals, Biotechnology and Life Sciences industry.
What are the specialties of Aeovian Pharmaceuticals?
Aeovian Pharmaceuticals specializes in mTORC1 pathway modulation, Selective therapeutics development, Treatment for tuberous sclerosis complex, CNS-penetrant inhibitor design, Innovative precision medicine solutions.
What products and services is Aeovian Pharmaceuticals likely to offer?
Aeovian Pharmaceuticals offers mTORC1 inhibitors, Neurological disorder therapeutics, Precision medicine solutions, Biopharmaceutical research services, Clinical trial support.
Who are the competitors of Aeovian Pharmaceuticals?
Competitors of Aeovian Pharmaceuticals are Sana Biotechnology, Arcus Biosciences, Kura Oncology, Scholar Rock, Evaxion Biotech, Molecular Partners, OncoOne, NantKwest.
What does Aeovian Pharmaceuticals do?
Aeovian Pharmaceuticals is a San Francisco-based biopharmaceutical company focused on developing innovative and selective therapeutics that target the mTORC1 pathway. Their work aims to address significant challenges in the biotechnology and life sciences fields, contributing to advancements in treatment options and patient care.
What are the social media links of Aeovian Pharmaceuticals?
Social media links of Aeovian Pharmaceuticals areTwitterLinkedIn